|
1A4R
G12V MUTANT OF HUMAN PLACENTAL CDC42 GTPASE IN THE GDP FORM
Deposited 1998-02-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–191(191 aa)
Chain B
1–191(191 aa)
|
Mutation:YES
Mutation:YES
|
MG MAGNESIUM ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
GNH AMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;pH 4.60
|
Resolution 2.50 Å
R-free 0.280
|
|
1AJE
CDC42 FROM HUMAN, NMR, 20 STRUCTURES
Deposited 1997-05-02
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–187(187 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;298 K
|
Resolution not provided
|
|
1AM4
COMPLEX BETWEEN CDC42HS.GMPPNP AND P50 RHOGAP (H. SAPIENS)
Deposited 1997-06-22
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
2–177(176 aa)
|
Mutation:M501P
|
MG MAGNESIUM ION × 1
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.9;pH 5.9
|
Resolution 2.70 Å
R-free 0.280
|
|
1AM4
COMPLEX BETWEEN CDC42HS.GMPPNP AND P50 RHOGAP (H. SAPIENS)
Deposited 1997-06-22
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
2–177(176 aa)
|
Mutation:M501P
|
MG MAGNESIUM ION × 1
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.9;pH 5.9
|
Resolution 2.70 Å
R-free 0.280
|
|
1AM4
COMPLEX BETWEEN CDC42HS.GMPPNP AND P50 RHOGAP (H. SAPIENS)
Deposited 1997-06-22
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
2–177(176 aa)
|
Mutation:M501P
|
MG MAGNESIUM ION × 1
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.9;pH 5.9
|
Resolution 2.70 Å
R-free 0.280
|
|
1AN0
CDC42HS-GDP COMPLEX
Deposited 1997-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–190(189 aa)
Chain B
2–190(189 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 2
GDP GUANOSINE-5'-DIPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.8;pH 4.8
|
Resolution 2.80 Å
R-free 0.344
|
|
1CEE
SOLUTION STRUCTURE OF CDC42 IN COMPLEX WITH THE GTPASE BINDING DOMAIN OF WASP
Deposited 1999-03-08
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–179(179 aa)
Fragment:CDC42
|
Not recorded
|
MG MAGNESIUM ION × 1
GCP PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 1
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 50mM;Pressure 1
|
Resolution not provided
|
|
1CF4
CDC42/ACK GTPASE-BINDING DOMAIN COMPLEX
Deposited 1999-03-23
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–191(191 aa)
|
Mutation:Q61L
|
MG MAGNESIUM ION × 1
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;298 K
NMR sample composition
[50%2H; 100%15N,13C]-labelled Cdc42, unlabelled f-ACK, 90% H2O/10% | 90% H2O/10% D2O
NMR sample composition
[U-15N] f-ACK, Cdc42, 90% H2O/10% | 90% H2O/10% D2O
NMR sample composition
[U-13C; U-15N] f-ACK, Cdc42, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
[U-13C; U-15N] Cdc42, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
[U-100% 15N] Cdc42, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
1DOA
Structure of the rho family gtp-binding protein cdc42 in complex with the multifunctional regulator rhogdi
Deposited 1999-12-20
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–188(188 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 2
GDP GUANOSINE-5'-DIPHOSPHATE × 1
GER GERAN-8-YL GERAN × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;291 K;15% PEG 4000,
100 mM Glutamic Acid,
25 mM MgSO4,
50 mM Tris,
2 mM NaN3,
2 mM LDAO
, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 18K, temperature 291K
|
Resolution 2.60 Å
R-free 0.320
|
|
1DOA
Structure of the rho family gtp-binding protein cdc42 in complex with the multifunctional regulator rhogdi
Deposited 1999-12-20
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–188(188 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 6
GDP GUANOSINE-5'-DIPHOSPHATE × 3
GER GERAN-8-YL GERAN × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.4;291 K;15% PEG 4000,
100 mM Glutamic Acid,
25 mM MgSO4,
50 mM Tris,
2 mM NaN3,
2 mM LDAO
, pH 7.4, VAPOR DIFFUSION, HANGING DROP, temperature 18K, temperature 291K
|
Resolution 2.60 Å
R-free 0.320
|
|
1E0A
Cdc42 complexed with the GTPase binding domain of p21 activated kinase
Deposited 2000-03-16
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–184(184 aa)
Fragment:1-184
|
Mutation:YES
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;298 K;Ionic strength (raw mmCIF value) 5 MM NA2HPO4, 25MM NACL;Pressure 1
NMR sample composition
90% WATER, 10% D2O
|
Resolution not provided
|
|
1EES
SOLUTION STRUCTURE OF CDC42HS COMPLEXED WITH A PEPTIDE DERIVED FROM P-21 ACTIVATED KINASE, NMR, 20 STRUCTURES
Deposited 2000-02-02
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–178(178 aa)
Fragment:AMINO ACIDS 1-178
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;298 K;Ionic strength (raw mmCIF value) 64 mM;Pressure ambient
NMR sample composition
0.8 mM U-15N,13C Cdc42Hs, 0.8 mM PBD46; 25 mM NaCl, 5 mM Na2PO4, 5 mM MgCl2, 1 mM NaN3, pH 5.5 | 90% H2O/10% D2O
NMR sample composition
0.8 mM U-15N Cdc42Hs, 0.8 mM PBD46; 25 mM NaCl, 5 mM Na2PO4, 5 mM MgCl2, 1 mM NaN3, pH 5.5 | 90% H2O/10% D2O
NMR sample composition
0.8 mM Cdc42Hs, 0.8 mM U-15N,13C PBD46; 25 mM NaCl, 5 mM Na2PO4, 5 mM MgCl2, 1 mM NaN3, pH 5.5 | 90% H2O/10% D2O
NMR sample composition
0.8 mM Cdc42Hs, 0.8 mM U-15N PBD46; 25 mM NaCl, 5 mM Na2PO4, 5 mM MgCl2, 1 mM NaN3, pH 5.5 | 90% H2O/10% D2O
NMR sample composition
0.8 mM 70%-2H,U-15N,13C Cdc42Hs, 0.8 mM PBD46; 25 mM NaCl, 5 mM Na2PO4, 5 mM MgCl2, 1 mM NaN3, pH 5.5 | 90% H2O/10% D2O
NMR sample composition
0.8 mM U-2H,15N Cdc42Hs, 0.8 mM PBD46; 25 mM NaCl, 5 mM Na2PO4, 5 mM MgCl2, 1 mM NaN3, pH 5.5 | 90% H2O/10% D2O
NMR sample composition
0.8 mM U-15N,13C Cdc42Hs, 0.8 mM PBD46; 25 mM NaCl, 5 mM Na2PO4, 5 mM MgCl2, 1 mM NaN3, pH 5.5 | 100% D2O
NMR sample composition
0.8 mM Cdc42Hs, 0.8 mM U-15N,13C PBD46; 25 mM NaCl, 5 mM Na2PO4, 5 mM MgCl2, 1 mM NaN3, pH 5.5 | 100% D2O
|
Resolution not provided
|
|
1GRN
CRYSTAL STRUCTURE OF THE CDC42/CDC42GAP/ALF3 COMPLEX.
Deposited 1998-07-30
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–191(191 aa)
Fragment:CDC42
|
Not recorded
|
MG MAGNESIUM ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
AF3 ALUMINUM FLUORIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;pH 6.0
|
Resolution 2.10 Å
R-free 0.259
|
|
1KI1
Guanine Nucleotide Exchange Region of Intersectin in Complex with Cdc42
Deposited 2001-12-02
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–188(188 aa)
Fragment:residues 1-188
|
Mutation:C188S
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;PEG 4000, ammonium sulfate, Tris, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.30 Å
R-free 0.247
|
|
1KI1
Guanine Nucleotide Exchange Region of Intersectin in Complex with Cdc42
Deposited 2001-12-02
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–188(188 aa)
Fragment:residues 1-188
|
Mutation:C188S
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;277 K;PEG 4000, ammonium sulfate, Tris, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.30 Å
R-free 0.247
|
|
1KZ7
Crystal Structure of the DH/PH Fragment of Murine Dbs in Complex with the Placental Isoform of Human Cdc42
Deposited 2002-02-06
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–188(188 aa)
Fragment:residues 1-188
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;PEG 8000, sodium formate, Tris HCL, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.40 Å
R-free 0.239
|
|
1KZ7
Crystal Structure of the DH/PH Fragment of Murine Dbs in Complex with the Placental Isoform of Human Cdc42
Deposited 2002-02-06
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–188(188 aa)
Fragment:residues 1-188
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;PEG 8000, sodium formate, Tris HCL, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.40 Å
R-free 0.239
|
|
1KZG
DbsCdc42(Y889F)
Deposited 2002-02-06
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–188(188 aa)
Fragment:residues 1-188
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;PEG 8000,Tris HCL, NaFormate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.60 Å
R-free 0.259
|
|
1KZG
DbsCdc42(Y889F)
Deposited 2002-02-06
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–188(188 aa)
Fragment:residues 1-188
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;PEG 8000,Tris HCL, NaFormate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K
|
Resolution 2.60 Å
R-free 0.259
|
|
1NF3
Structure of Cdc42 in a complex with the GTPase-binding domain of the cell polarity protein, Par6
Deposited 2002-12-12
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–181(180 aa)
|
Mutation:Q61L
|
MG MAGNESIUM ION × 1
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;293 K;24% PEG 4000, 100mM sodium citrate, 0.2M ammonium acetate, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.273
|
|
1NF3
Structure of Cdc42 in a complex with the GTPase-binding domain of the cell polarity protein, Par6
Deposited 2002-12-12
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–181(180 aa)
|
Mutation:Q61L
|
MG MAGNESIUM ION × 1
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;293 K;24% PEG 4000, 100mM sodium citrate, 0.2M ammonium acetate, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.273
|
|
1NF3
Structure of Cdc42 in a complex with the GTPase-binding domain of the cell polarity protein, Par6
Deposited 2002-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2–181(180 aa)
Chain B
2–181(180 aa)
|
Mutation:Q61L
Mutation:Q61L
|
MG MAGNESIUM ION × 2
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;293 K;24% PEG 4000, 100mM sodium citrate, 0.2M ammonium acetate, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.10 Å
R-free 0.273
|
|
2ASE
NMR structure of the F28L mutant of Cdc42Hs
Deposited 2005-08-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–178(178 aa)
|
Mutation:F28L
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;298 K;Ionic strength (raw mmCIF value) 30 mM;Pressure ambient
NMR sample composition
U-15N Cdc42Hs, 25 mM phosphate buffer, 5 mM MgCl2, pH 5.5, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
U-15N Cdc42Hs, 25 mM phosphate buffer, 5 mM MgCl2, pH 5.5, 100% D2O | 100% D2O
NMR sample composition
Cdc42Hs, 25 mM phosphate buffer, 5 mM MgCl2, pH 5.5, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2DFK
Crystal structure of the CDC42-Collybistin II complex
Deposited 2006-03-02
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–191(191 aa)
|
Not recorded
|
GOL GLYCEROL × 4
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;PEG 8000, Potassium dihydrogen phosphate, NaCl, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K, pH 8.00
|
Resolution 2.15 Å
R-free 0.229
|
|
2DFK
Crystal structure of the CDC42-Collybistin II complex
Deposited 2006-03-02
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–191(191 aa)
|
Not recorded
|
GOL GLYCEROL × 2
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;PEG 8000, Potassium dihydrogen phosphate, NaCl, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K, pH 8.00
|
Resolution 2.15 Å
R-free 0.229
|
|
2DFK
Crystal structure of the CDC42-Collybistin II complex
Deposited 2006-03-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–191(191 aa)
Chain D
1–191(191 aa)
|
Not recorded
|
GOL GLYCEROL × 6
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;PEG 8000, Potassium dihydrogen phosphate, NaCl, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K, pH 8.00
|
Resolution 2.15 Å
R-free 0.229
|
|
2KB0
Cdc42(T35A)
Deposited 2008-11-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–178(178 aa)
|
Mutation:T35A
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.5;298 K;Pressure ambient
NMR sample composition
0.4 mM [U-100% 13C; U-100% 15N] Cdc42(T35A), 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2NGR
TRANSITION STATE COMPLEX FOR GTP HYDROLYSIS BY CDC42: COMPARISONS OF THE HIGH RESOLUTION STRUCTURES FOR CDC42 BOUND TO THE ACTIVE AND CATALYTICALLY COMPROMISED FORMS OF THE CDC42-GAP.
Deposited 1998-07-31
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–191(191 aa)
Fragment:FULL-LENGTH CDC42 IN COMPLEX WITH A C-TERMINAL ACTIVE DOMAIN OF CDC42GAP(R305A) MUTANT.
|
Not recorded
|
MG MAGNESIUM ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
AF3 ALUMINUM FLUORIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;pH 6.0
|
Resolution 1.90 Å
R-free 0.293
|
|
2ODB
The crystal structure of human cdc42 in complex with the CRIB domain of human p21-activated kinase 6 (PAK6)
Deposited 2006-12-22
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–181(181 aa)
|
Not recorded
|
CL CHLORIDE ION × 1
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 3
GCP PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;293 K;0.1M acetate, 2M (NH4)2SO4, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.40 Å
R-free 0.232
|
|
2ODB
The crystal structure of human cdc42 in complex with the CRIB domain of human p21-activated kinase 6 (PAK6)
Deposited 2006-12-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–181(181 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 6
GCP PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;293 K;0.1M acetate, 2M (NH4)2SO4, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.40 Å
R-free 0.232
|
|
2ODB
The crystal structure of human cdc42 in complex with the CRIB domain of human p21-activated kinase 6 (PAK6)
Deposited 2006-12-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–181(181 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 6
GCP PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;293 K;0.1M acetate, 2M (NH4)2SO4, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.40 Å
R-free 0.232
|
|
2ODB
The crystal structure of human cdc42 in complex with the CRIB domain of human p21-activated kinase 6 (PAK6)
Deposited 2006-12-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–181(181 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 6
GCP PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.5;293 K;0.1M acetate, 2M (NH4)2SO4, pH 4.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.40 Å
R-free 0.232
|
|
2QRZ
Cdc42 bound to GMP-PCP: Induced Fit by Effector is Required
Deposited 2007-07-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–189(189 aa)
Chain B
1–189(189 aa)
|
Not recorded
|
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 1
GCP PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;12% PEG 6K, 100 mM Na Acetate, 50 mM MES, pH 6.0, 100 mM Ammonium Sulfate, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.40 Å
R-free 0.263
|
|
2WM9
Structure of the complex between DOCK9 and Cdc42.
Deposited 2009-06-30
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–188(188 aa)
|
Not recorded
|
GOL GLYCEROL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;THE PROTEIN WAS CONCENTRATED TO 6 MG/ML. CRYSTALS WERE GROWN USING HANGING DROP VAPOUR DIFFUSION. 1 UL OF COMPLEX WITH 200 MM NDSB-201 ADDED TO PROTEIN PRIOR TO CRYSTALLIZATION WAS MIXED WITH EQUAL VOLUME OF CRYSTALLIZATION BUFFER: 14% (W/V) PEG3350,100 MM MES (PH 6.0), 200 MM AMMONIUM ACETATE, 12% GLYCEROL. CRYSTALS WERE GROWN AT 20C.
|
Resolution 2.20 Å
R-free 0.251
|
|
2WMN
Structure of the complex between DOCK9 and Cdc42-GDP.
Deposited 2009-07-02
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–188(188 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;pH 6.0
|
Resolution 2.39 Å
R-free 0.276
|
|
2WMO
Structure of the complex between DOCK9 and Cdc42.
Deposited 2009-07-02
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–188(188 aa)
|
Not recorded
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;pH 6.0
|
Resolution 2.20 Å
R-free 0.272
|
|
3GCG
crystal structure of MAP and CDC42 complex
Deposited 2009-02-22
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–178(177 aa)
Fragment:UNP residues 2-178
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;293 K;0.1M Hepes pH 7.5, 10% PEG 6000, 5% MPD, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.30 Å
R-free 0.277
|
|
3QBV
Structure of designed orthogonal interaction between CDC42 and nucleotide exchange domains of intersectin
Deposited 2011-01-14
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–178(178 aa)
Fragment:UNP Residues 1-178
|
Mutation:F56R
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;295 K;100mm TRIS pH 7.5, 25% PEG 3350, 150mm ammonium sulfate, and 1mM DTT, temperature 295k, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.65 Å
R-free 0.284
|
|
3QBV
Structure of designed orthogonal interaction between CDC42 and nucleotide exchange domains of intersectin
Deposited 2011-01-14
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–178(178 aa)
Fragment:UNP Residues 1-178
|
Mutation:F56R
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;295 K;100mm TRIS pH 7.5, 25% PEG 3350, 150mm ammonium sulfate, and 1mM DTT, temperature 295k, VAPOR DIFFUSION, HANGING DROP
|
Resolution 2.65 Å
R-free 0.284
|
|
3VHL
Crystal structure of the DHR-2 domain of DOCK8 in complex with Cdc42 (T17N mutant)
Deposited 2011-08-26
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–188(188 aa)
|
Mutation:T17N, C188S
|
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.2M Potassium phosphate, 20% PEG 3350, pH 8.0, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.08 Å
R-free 0.232
|
|
4DID
Crystal structure of Salmonella effector N-terminal domain SopB in complex with Cdc42
Deposited 2012-01-30
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–183(183 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.2;277 K;0.2M sodium chloride, 0.1M phosphate-citrate pH 4.2, 20% PEG 8000, VAPOR DIFFUSION, SITTING DROP, temperature 277K
|
Resolution 2.35 Å
R-free 0.237
|
|
4ITR
Crystal Structure of IbpAFic2-H3717A in complex with adenylylated Cdc42
Deposited 2013-01-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–191(191 aa)
Chain D
1–191(191 aa)
|
Not recorded
|
SO4 SULFATE ION × 4
AMP ADENOSINE MONOPHOSPHATE × 2
GDP GUANOSINE-5'-DIPHOSPHATE × 2
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;277 K;PEG 3350, Bis-Tris, (NH4)2SO4, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.0K
|
Resolution 2.30 Å
R-free 0.226
|
|
4JS0
Complex of Cdc42 with the CRIB-PR domain of IRSp53
Deposited 2013-03-22
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–178(178 aa)
|
Mutation:G12V
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 2
PE4 2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHOXY]-ETHOXY}-ETHANOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;291 K;18-20% PEG 4000, 0.2M magnesium chloride, 0.004M betain hydrochloride, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 1.90 Å
R-free 0.199
|
|
4YC7
Crystal structure of human FMNL2 GBD-FH3 Domains bound to Cdc42-GppNHp
Deposited 2015-02-19
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–179(179 aa)
Fragment:UNP residues 1-179
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;20 mM Tris/HCl (pH 8.0), 14% (v/v) PEG 3350, 0.25 M magnesium acetate
|
Resolution 2.50 Å
R-free 0.253
|
|
4YDH
The structure of human FMNL1 N-terminal domains bound to Cdc42
Deposited 2015-02-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–179(179 aa)
Chain D
1–179(179 aa)
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;17% (v/v) PEG 3350, 0.16 M tri-ammonium citrate
|
Resolution 3.80 Å
R-free 0.281
|
|
5FI1
Crystal Structure of the P-Rex1 DH/PH tandem in complex with Cdc42
Deposited 2015-12-22
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–191(191 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;294 K;Ammonium citrate, PEG 3350
|
Resolution 3.20 Å
R-free 0.198
|
|
5HZK
Crystal structure of photoinhibitable Intersectin1 containing wildtype LOV2 domain in complex with Cdc42
Deposited 2016-02-02
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–188(188 aa)
|
Mutation:C188S
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
FMN FLAVIN MONONUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;0.1 M MES, 20% (w/v) PEG 6000
|
Resolution 3.30 Å
R-free 0.257
|
|
5HZK
Crystal structure of photoinhibitable Intersectin1 containing wildtype LOV2 domain in complex with Cdc42
Deposited 2016-02-02
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–188(188 aa)
|
Mutation:C188S
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
FMN FLAVIN MONONUCLEOTIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6;293 K;0.1 M MES, 20% (w/v) PEG 6000
|
Resolution 3.30 Å
R-free 0.257
|
|
5UPK
CDC42 binds PAK4 via an extended GTPase-effector interface - 3 peptide: PAK4cat, PAK4-N45, CDC42
Deposited 2017-02-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–177(177 aa)
|
Mutation:Q61L
|
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 1
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;295 K;0.1M HEPES pH 7.5, 22% PEG1,000
|
Resolution 2.40 Å
R-free 0.264
|
|
5UPL
CDC42 binds PAK4 via an extended GTPase-effector inteface - 2 peptide: PAK4FL, CDC42 - UNREFINED
Deposited 2017-02-03
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–177(177 aa)
Fragment:UNP residues 1-177
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;295 K;0.1M Tris-HCl pH 8.5, 50mM Na2SO4, 6% PEG6000
|
Resolution 3.00 Å
R-free 0.310
|
|
6AJ4
Crystal structure of the DHR-2 domain of DOCK7 in complex with Cdc42
Deposited 2018-08-27
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–188(188 aa)
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;PEG3350 and tri-potassium citrate monohydrate
|
Resolution 3.26 Å
R-free 0.259
|
|
6AJ4
Crystal structure of the DHR-2 domain of DOCK7 in complex with Cdc42
Deposited 2018-08-27
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–188(188 aa)
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;PEG3350 and tri-potassium citrate monohydrate
|
Resolution 3.26 Å
R-free 0.259
|
|
6AJ4
Crystal structure of the DHR-2 domain of DOCK7 in complex with Cdc42
Deposited 2018-08-27
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
1–188(188 aa)
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;PEG3350 and tri-potassium citrate monohydrate
|
Resolution 3.26 Å
R-free 0.259
|
|
6AJ4
Crystal structure of the DHR-2 domain of DOCK7 in complex with Cdc42
Deposited 2018-08-27
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
1–188(188 aa)
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;PEG3350 and tri-potassium citrate monohydrate
|
Resolution 3.26 Å
R-free 0.259
|
|
6AJL
DOCK7 mutant I1836Y complexed with Cdc42
Deposited 2018-08-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–188(188 aa)
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;PEG3350, tri-potassium citrate monohydrate
|
Resolution 3.23 Å
R-free 0.259
|
|
6AJL
DOCK7 mutant I1836Y complexed with Cdc42
Deposited 2018-08-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–188(188 aa)
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;PEG3350, tri-potassium citrate monohydrate
|
Resolution 3.23 Å
R-free 0.259
|
|
6AJL
DOCK7 mutant I1836Y complexed with Cdc42
Deposited 2018-08-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
1–188(188 aa)
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;PEG3350, tri-potassium citrate monohydrate
|
Resolution 3.23 Å
R-free 0.259
|
|
6AJL
DOCK7 mutant I1836Y complexed with Cdc42
Deposited 2018-08-28
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
1–188(188 aa)
|
Mutation:C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;PEG3350, tri-potassium citrate monohydrate
|
Resolution 3.23 Å
R-free 0.259
|
|
6SIU
Crystal structure of IbpAFic2 covalently tethered to Cdc42
Deposited 2019-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–191(191 aa)
Chain D
1–191(191 aa)
|
Not recorded
|
SO4 SULFATE ION × 10
GDP GUANOSINE-5'-DIPHOSPHATE × 2
GOL GLYCEROL × 2
LJN [(2~{R},3~{S},4~{R},5~{R})-5-[4-(acetamidomethyl)-1,2,3-triazol-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methyl dihydrogen phosphate × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;292 K;1.6 M ammonium sulfate and 0.1 M citric acid
|
Resolution 2.49 Å
R-free 0.239
|
|
6SUP
Crystal Structure of TcdB2-TccC3-Cdc42
Deposited 2019-09-16
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
167–179(13 aa)
|
Not recorded
|
MG MAGNESIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 4.6;293.15 K;0.1 M sodium chloride, 0.1 M magnesium chloride, 0.1 M tri-sodium citrate pH 5.5, 12 % PEG 4000
Seeding: 0.1 M magnesium chloride, 0.1 M tri-sodium acetate pH 4.6, 12 % PEG 6000
|
Resolution 2.00 Å
R-free 0.320
|
|
6TKZ
Crystal structure of the DHR2 domain of DOCK10 in complex with CDC42
Deposited 2019-11-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: dimeric
|
Chain C
1–188(188 aa)
Chain D
1–188(188 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 2
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 7.5;293 K;25% (w/v) PEG 3350, 200 mM potassium acetate, 8% (v/v) 1,1,1,3,3,3-Hexafluoro-2-propanol.
|
Resolution 2.64 Å
R-free 0.274
|
|
6TKZ
Crystal structure of the DHR2 domain of DOCK10 in complex with CDC42
Deposited 2019-11-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: dimeric
|
Chain C
1–188(188 aa)
Chain D
1–188(188 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 2
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION;pH 7.5;293 K;25% (w/v) PEG 3350, 200 mM potassium acetate, 8% (v/v) 1,1,1,3,3,3-Hexafluoro-2-propanol.
|
Resolution 2.64 Å
R-free 0.274
|
|
7S0Y
Structures of TcdB in complex with Cdc42
Deposited 2021-08-31
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
4–179(176 aa)
|
Not recorded
|
MN MANGANESE (II) ION × 1
UDP URIDINE-5'-DIPHOSPHATE × 1
SO4 SULFATE ION × 11
GDP GUANOSINE-5'-DIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;0.1 M sodium cacodylate (pH 6.6), 2.4 M ammonium sulfate, and 2.5% (v/v) Jeffamine M-600 (pH 7.0)
|
Resolution 2.79 Å
R-free 0.259
|
|
8I5F
Crystal structure of the DHR-2 domain of DOCK10 in complex with Cdc42 (T17N mutant)
Deposited 2023-01-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–188(188 aa)
Chain D
1–188(188 aa)
|
Mutation:T17N, C188S
Mutation:T17N, C188S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;PEG 8000, sodium chloride
|
Resolution 2.80 Å
R-free 0.296
|
|
9GRM
Cdc42 in complex with inhibitory peptide
Deposited 2024-09-11
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–184(184 aa)
Fragment:1-184
|
Mutation:Q61L
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
SOLUTION NMR
NMR measurement conditions
pH 6.8;298 K;Ionic strength (raw mmCIF value) 200;Pressure 1
NMR sample composition
0.48 mM [U-100% 15N] Cdc42, 0.58 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.4 mM [U-13C; U-15N] Cdc42, 0.45 mM None Peptide, 50 mM None sodium phosphate, 150 mM None sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.415 mM [U-100% 15N] Peptide, 0.45 mM None Cdc42, 50 mM None sodium phosphate, 150 mM None sodium chloride, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
9VM2
Structure of DOCK6-Cdc42 complex protomer
Deposited 2025-06-27
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–187(187 aa)
|
Mutation:G15A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 3.94 Å
|
|
9VM3
Structure of DOCK6-Cdc42 complex
Deposited 2025-06-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
1–187(187 aa)
Chain D
1–187(187 aa)
|
Mutation:G15A
Mutation:G15A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
mmCIF provides none of the parsed conditions
|
Resolution 4.52 Å
|